Salarius Pharmaceuticals Inc (SLRX)
0.50
+0.01
(+2.06%)
USD |
NASDAQ |
May 17, 16:00
0.50
0.00 (0.00%)
After-Hours: 20:00
Salarius Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2021 | -538.1% |
| March 31, 2021 | -146.0% |
| December 31, 2020 | -119.5% |
| September 30, 2020 | -124.6% |
| June 30, 2020 | -143.5% |
| March 31, 2020 | -183.9% |
| December 31, 2019 | -181.3% |
| September 30, 2019 | -300.3% |
| June 30, 2019 | -100.9% |
| March 31, 2019 | -2.12K% |
| December 31, 2018 | -1.23K% |
| Date | Value |
|---|---|
| September 30, 2018 | -1.05K% |
| June 30, 2018 | -3.69K% |
| March 31, 2018 | -4.60K% |
| December 31, 2017 | -2.84K% |
| September 30, 2017 | -2.26K% |
| June 30, 2017 | -2.62K% |
| March 31, 2017 | -3.41K% |
| December 31, 2016 | -2.64K% |
| September 30, 2016 | -1.78K% |
| June 30, 2016 | -10.08K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-538.1%
Minimum
Jun 2021
-100.9%
Maximum
Jun 2019
-204.2%
Average
-146.0%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Masimo Corp | 3.84% |
| Esperion Therapeutics Inc | 44.30% |
| SINTX Technologies Inc | -398.1% |
| Flora Growth Corp | -56.23% |
| NovaBay Pharmaceuticals Inc | -122.2% |